| 1 |
Siegel RL，Giaquinto AN，Jemal A. Cancer statistics，2024［J］. CA Cancer J Clin，2024，74（1）：12-49.
|
| 2 |
Zhou Q，Yu Y，Xing L，et al. First-line zorifertinib for EGFR-mutant non-small cell lung cancer with central nervous system metastases：The phase 3 EVEREST trial［J］. Med，2024，6（1）：100513.
|
| 3 |
Wang Y，Xu R，Zhang D，et al. Circ-ZKSCAN1 regulates FAM83A expression and inactivates MAPK signaling by targeting miR-330-5p to promote non-small cell lung cancer progression［J］. Transl Lung Cancer Res，2019，8（6）：862-875.
|
| 4 |
骆晨雨，周月阳，李 娜，等. 中国癌症疾病负担及三级预防现状［J］. 中华流行病学杂志，2024，45（5）：621-625.
|
| 5 |
Zhu J，Yang J，Chen X，et al. Integrated bulk and single-cell RNA sequencing data constructs and validates a prognostic model for nonsmall cell lung cancer ［J］. J Cancer，2024，15（3）：796-808.
|
| 6 |
Xu JY，Zhang C，Wang X，et al. Integrative proteomic characterization of human lung adenocarcinoma［J］. Cell，2020，182（1）：245-261 e17.
|
| 7 |
曹立宇，田壮壮，祝利利，等. WHO（2020）女性生殖系统肿瘤分子分型在子宫内膜癌中的应用与临床意义［J］. 临床与实验病理学杂志，2024，40（3）：279-284.
|
| 8 |
Mcgranahan N，Swanton C. Clonal heterogeneity and tumor evolution：Past，present，and the Future［J］. Cell，2017，168（4）：613-628.
|
| 9 |
Lin S，Gregory RI. MicroRNA biogenesis pathways in cancer［J］.Nat Rev Cancer，2015，15（6）：321-333.
|
| 10 |
Wang L，Hu Z，Bai H，et al. miRNA-105-5p regulates the histone deacetylase HDAC2 through FOXG1 to affect the malignant biological behavior of triple-negative breast cancer cells［J］. Am J Med Sci，2024：S0002-9629（24）01476-9.
|
| 11 |
Tai MC，Bantis LE，Parhy G，et al. Circulating microRNA panel for prediction of recurrence and survival in early-stage Lung Adenocarcinoma［J］. Int J Mol Sci，2024，25（4）：2331.
|
| 12 |
D'agostino E，Muro A，Sgueglia G，et al. Exosomal microRNAs：Comprehensive methods from exosome isolation to miRNA extraction and purity analysis［J］. Methods Mol Biol，2023，2595：75-92.
|
| 13 |
Cheng Z，Kong Y，Xu H，et al. Extracellular vesicles derived from stored red blood cell suspensions enhance invasion and migration of lung cancer cells by miR1246 and miR150-3p［J］. Vox Sang，2024，119（8）：809-820.
|
| 14 |
Siniscalco D，Galderisi U，Peluso G，et al. Circulating microRNAs in cancer：A 5-year update with a focus on breast and lung cancers［J］. Int J Mol Sci，2024，25（6）：3140.
|
| 15 |
Dai H，Li L，Yang Y，et al. Screening microRNAs as potential prognostic biomarkers for lung adenocarcinoma［J］. Ann Med，2023，55（2）：2241013.
|
| 16 |
Ezzatifar F，Rafiei A，Valadan R，et al.Detection of novel autoantibodies to nucleolin's RNA-binding domains as a serum tumor biomarker through ELISA［J］. Iran J Allergy Asthma Immunol，2022，21（6）：616-625.
|
| 17 |
Xi Y，Zhang Y，Fang J，et al. Development of monoclonal antibodies and characterization of an ELISA platform against kallikrein-related peptidase 6 as a tumor biomarker［J］. Monoclon Antib Immunodiagn Immunother，2015，34（5）：346-353.
|
| 18 |
Rizou T，Perlikos F，Lagiou M，et al. Development of novel realtime RT-qPCR methodologies for quantification of the COL11A1 mRNA general and C transcripts and evaluation in non-small cell lung cancer specimens［J］. J BUON，2018，23（6）：1699-1710.
|
| 19 |
Li Y，Zhou B，Yang Y，et al. Expression and clinical relevance of serum LncRNA NEAT1 and microRNA-31 in patients with advanced lung cancer and pulmonary infection［J］. Altern Ther Health Med，2024：AT9614.
|
| 20 |
Kang JE，Kim H，Lee YH，et al. Unveiling Cas12j trans-cleavage activity for CRISPR diagnostics：Application to miRNA detection in lung cancer diagnosis［J］. Adv Sci （Weinh），2024，e2402580.
|
| 21 |
杨 慧，郭丽娟，冯晓丹，等. 非小细胞肺癌铂类药物耐药mi RNA 表达特征及预测分析［J/CD］. 中华肺部疾病杂志（电子版），2024，17（5）：719-724.
|
| 22 |
Yadav R，Khatkar R，Yap KC，et al. The miRNA and PD-1/PD-L1 signaling axis：an arsenal of immunotherapeutic targets against lung cancer［J］. Cell Death Discov，2024，10（1）：414.
|
| 23 |
Tanigawa K，Misono S，Mizuno K，et al.MicroRNA signature of smallcell lung cancer after treatment failure：impact on oncogenic targets by miR-30a-3p control［J］. Mol Oncol，2023，17（2）：328-343.
|
| 24 |
Aguilar-Martinez SY，Campos-viguri GE，Medina-Garcia SE，et al.MiR-21 regulates growth and migration of cervical cancer cells by RECK signaling pathway［J］. Int J Mol Sci，2024，25（7）：4086.
|
| 25 |
戴 随，张贺平，褚翔南，等. miR-325-3p 通过CCL19 基因调控非小细胞肺癌脑部转移的发展［J］. 河南大学学报（医学版），2024，43（1）：35-41.
|
| 26 |
Desouky EM，Khaliefa AK，Hozayen WG，et al. Signature of miR-21 and MEG-2 and their correlation with TGF-beta signaling in breast cancer［J］. Hum Exp Toxicol，2023，42：9603271231159799.
|
| 27 |
Bostanshirin N，Hajikhani B，Vaezi AA，et al. Association between colorectal cancer and expression levels of miR-21，miR-17-5P，miR-155 genes and the presence of Fusobacterium nucleatum in biopsy samples obtained from Iranian patients［J］. Infect Agent Cancer，2023，18（1）：14.
|
| 28 |
Asghariazar V，Makaremi S，Zare E，et al. Oleuropein induces apoptosis in gastric cancer cell lines by regulating mir-34a，mir-21，and related genes：an experimental and bioinformatic study［J］. Int J Biol Macromol，2024，265（Pt 1）：130527.
|
| 29 |
Ma Z，Chen G，Chen Y，et al. MiR-937-3p promotes metastasis and angiogenesis and is activated by MYC in lung adenocarcinoma［J］.Cancer Cell Int，2022，22（1）：31.
|